Timing of Energy Availability on Menstrual Cycle Function
FAST
Implications for the Timing of Energy Availability on Menstrual Cycle Function
1 other identifier
interventional
64
1 country
1
Brief Summary
The primary aim of this clinical trial is to evaluate how fasted prolonged exercise may influence circulating reproductive hormones (i.e., estradiol, progesterone, luteinizing hormone) and menstrual cycle length when energy availability is maintained at or above 30 kcal/kg lean body mass/ day among women who regularly do running or cycling exercise. A secondary aim is to determine the effects of fasted prolonged exercise on serum leptin and cortisol. Participants will be asked to do the following over a \~3 month enrollment period:
- attend a laboratory visit at the beginning of the study to have their resting metabolic rate, aerobic fitness, and body composition tested
- monitor their menstrual cycle length, urine hormones, perceived stress levels, and diet for \~3 months
- complete 3, 90-minute exercise sessions on a stationary bike or treadmill either fed (consuming a carbohydrate meal 1 h prior and 0.7 g carbohydrate/ kg body mass/ h during exercise) or fasted (consuming no meal prior and no carbohydrates during exercise) during month \~3
- saliva samples will be taken prior to and after 90-minute exercise sessions for quantification of leptin and cortisol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2027
May 1, 2026
April 1, 2026
3.1 years
June 17, 2024
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Urinary estrone-3-glucuronide (E3G)
ng/mL
3 months
Urinary pregnanediol glucuronide (PdG)
ug/mL
3 months
Urinary luteinizing hormone (LH)
MIU/mL
3 months
Menstrual cycle length
days
3 months
Secondary Outcomes (2)
Salivary cortisol
3 days
Salivary leptin
3 days
Study Arms (2)
Fed with Carbohydrates
EXPERIMENTALParticipants will complete 3, 90-minute stationary cycle or treadmill exercise sessions 1 h after consuming a meal containing 1 g carbohydrate/ kg body weight. During exercise, they will consume an artificially sweetened beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose.
Fasted without Carbohydrates
PLACEBO COMPARATORParticipants will complete 3, 90-minute stationary cycle or treadmill exercise sessions following an overnight fast. During exercise, they will consume an artificially sweetened beverage containing no carbohydrates.
Interventions
Beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose and artificial sweetener
Beverage containing no carbohydrates or kilocalories and an artificial sweetener
Eligibility Criteria
You may qualify if:
- participates in structured running or cycling exercise for at least 30 minutes on 3 or more days per week
- accustomed to exercising for 90 minutes or more
- has regular periods every 21-35 days
- have not taken hormonal contraceptives for at least the past 6 months
- is not currently or trying to become pregnant or breastfeeding, and has not been pregnant or breastfeeding in the past 12 months
- does not currently have a diagnosis of a major menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
- does not currently have a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes, congenital adrenal hyperplasia)
- does not currently have a major cardiovascular or respiratory disease
You may not qualify if:
- miss more than 7 consecutive days of aerobic activity (i.e., running, cycling, cross training)
- demonstrate clinical low energy availability as defined as energy availability \<30 kcal/kg fat free mass
- report menstrual cycle lengths \<21 or \>35 days in the first 2 months of at-home monitoring
- do not demonstrate an anticipated rise in luteinizing hormone and progesterone in the first 2 months of at-home monitoring
- begin taking a hormonal contraceptive
- become pregnant
- are diagnosed with a menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine, or endometrial cancer)
- are diagnosed with a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes)
- are diagnosed with a major cardiovascular or respiratory disease
- are unable to follow instructions for any of the procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
William J. Hybl Sports Medicine and Performance Center
Colorado Springs, Colorado, 80918, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 17, 2024
First Posted
June 24, 2024
Study Start
August 1, 2024
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share